Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drug conjugates
Pharma
Daiichi, AZ's Enhertu nabs 7th FDA nod in breast cancer first
The FDA has cleared AZ and Daiichi Sankyo's Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer after one or more endocrine therapies
Kevin Dunleavy
Jan 28, 2025 10:19am
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
Jan 17, 2025 9:14pm
Daiichi Sankyo builds $152M ADC plant in China
Dec 11, 2024 9:47am
ASH: GSK details Blenrep's survival win against J&J's Darzalex
Dec 9, 2024 1:30pm
Kelun's Merck-partnered TROP2 ADC snags first nod in China
Nov 27, 2024 10:56am
GSK's ADC Blenrep delivers survival win against J&J's Darzalex
Nov 14, 2024 9:24am